|
MechanismCalpain1/2 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Cortex Pharmaceuticals, Inc. /Private Group/
0 Patents (Medical) associated with Cortex Pharmaceuticals, Inc. /Private Group/
100 Deals associated with Cortex Pharmaceuticals, Inc. /Private Group/
100 Translational Medicine associated with Cortex Pharmaceuticals, Inc. /Private Group/